Delivery Order SPE2DB24D2101-SPE2DB25FKPYW
- Not listed
- The Defense Logistics Agency awarded a $23.73K delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Veozah 45 mg tablets (30-count units). This non-set-aside contract was competitively awarded on a firm fixed-price basis with an ultimate completion date of September 29, 2025. The ordering activity reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement, with performance to be fulfilled at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,976.56 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Veozah 45 mg tablets (30-count package) valued at $1,532.04. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by August 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,768.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract is non-set-aside and competitively awarded, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.28 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction under a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.24 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Veozah 45 mg tablets (30-count units) at a ceiling value of $1,582.61. This competitive award, which carries no set-aside designation, represents a firm fixed price delivery order and is expected to be completed by September 11, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,292.12 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,866.44 to AmerisourceBergen Drug Corp for 30-count tablets of Veozah 45 mg, a pharmaceutical product to support federal medical procurement needs. This non-set-aside, competitively awarded contract is classified as firm fixed price and was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Veozah 45 mg, valued at $1,745.16, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPYWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,994.88 on September 24, 2025, for the supply of Veozah 45 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is issued under AmerisourceBergen's comprehensive Pharmaceutical Prime Vendor Global Program IDC valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements for DLA and its associated customers, including the Defense Health Agency and other government healthcare systems, demonstrating its established capability to meet federal supply standards and delivery timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/24/25 |